Table 2.
Proportional hazard model after propensity score matching for disease-free survival.
| MULTIVARIABLE HR (95% CI) |
||
|---|---|---|
| Age in years | 1.01 (0.99–1.03) | p=0.35 |
|
| ||
| Stage | p=0.03* | |
| 1b1 | 1.00 | |
| 1b2 | 2.18 (1.16–4.08) | |
| 2a1 | 2.00 (0.73–5.52) | |
|
| ||
| LVSI | p=0.005* | |
| No | 1.00 | |
| Yes | 1.79 (1.15–2.78) | |
| unknown | 0.82 (0.48–1.43) | |
|
| ||
| Grade | p=0.002* | |
| 1 | 1.00 | |
| 2 | 4.14 (1.63–10.54) | |
| 3 | 2.08 (0.71–6.12) | |
|
| ||
| Adjuvant therapy | p=0.99 | |
| No | 1.00 | |
| Yes | 1.00 (0.59–1.70) | |
|
| ||
| Diameter | p<0.001* | |
| ≤ 20 mm | 1.00 | |
| > 20 mm | 2.32 (1.53–3.51) | |
|
| ||
| Surgical Approach | p<0.001* | |
| Open | 1.00 | |
| Others | 2.65 (1.78–3.95) | |
|
| ||
| Histotype | p=0.003* | |
| Squamous | 1.00 | |
| Adenocarcinoma | 1.27 (0.81–1.99) | |
| Other | 2.77 (1.53–5.02) | |
|
| ||
| Number of radical hysterectomies per year | p=0.001* | |
| <7 | 1.00 | |
| 7–17 | 0.58 (0.31–1.09) | |
| >17 | 0.32 (0.17–0.61) | |
*
p<0.05